Cargando…
Synthesis and Biological Activities of Some New Benzotriazinone Derivatives Based on Molecular Docking; Promising HepG2 Liver Carcinoma Inhibitors
[Image: see text] In one-pot strategy, diazotization of methyl anthranilate 5 followed by addition of amino acid ester hydrochloride, we have prepared methyl-2-(4-oxobenzotriazin-3(4H)-yl)alkanoates 6a–c. Starting with hydrazides 7a,b, N-alkyl-2-(4-oxobenzotriazin-3(4H)-yl)alkanamides 9–10(a–h) and...
Autores principales: | El Rayes, Samir M., Ali, Ibrahim A. I., Fathalla, Walid, Mahmoud, Mostafa A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114758/ https://www.ncbi.nlm.nih.gov/pubmed/32258913 http://dx.doi.org/10.1021/acsomega.0c00116 |
Ejemplares similares
-
Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines
por: Safwat, Ghada M., et al.
Publicado: (2021) -
Experimental and Computational Analysis of Newly Synthesized Benzotriazinone Sulfonamides as Alpha-Glucosidase Inhibitors
por: Khalid, Zunera, et al.
Publicado: (2022) -
HepGentox: a novel promising HepG2 reportergene-assay for the detection of genotoxic substances in complex mixtures
por: Pinter, Elisabeth, et al.
Publicado: (2021) -
Synthesis and antitumor activity against HepG-2, PC-3, and HCT-116 cells of some naphthyridine and pyranopyridinecarbonitrile derivatives
por: Mohamed, S. F., et al.
Publicado: (2017) -
Lipid synthesis and secretion in HepG2 cells is not affected by ACTH
por: Skoog, Maria, et al.
Publicado: (2010)